Multiple Sclerosis: An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options

  title={Multiple Sclerosis: An Overview of Clinical Features, Pathophysiology, Neuroimaging, and Treatment Options},
  author={Alireza Minagar},
  journal={Colloquium Series on Integrated Systems Physiology: From Molecule To Function},
  • A. Minagar
  • Published 9 September 2014
  • Biology, Psychology, Medicine
  • Colloquium Series on Integrated Systems Physiology: From Molecule To Function
Abstract Download Free Sample Multiple sclerosis [MS] is one of the most common auto-immune-mediated diseases of the human central nervous system [CNS] which affects young adults and usually causes significant neurological disability. Currently, the causes of MS are still unclear, a cure for MS remains elusive and the effectiveness of treatment varies significantly among individuals. Clinical features and neurological deficits stemming from this progressive neurological disease are diverse… 
Central Neuropathic Pain and Profiles of Quantitative Electroencephalography in Multiple Sclerosis Patients
In MS patients with CNP, the frequencies of the dominant spectral power (peak frequencies) in the high-frequency beta band were higher than in the healthy control in posterior areas of the left hemisphere.
Development of a model of Saint Louis encephalitis infection and disease in mice
It is indicated that the central nervous system (CNS) inflammation is a major component of SLEV-induced disease, recapitulating several aspects of St. Louis encephalitis in humans.
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Systematic reviews of the clinical effectiveness and cost-effectiveness of IFN-β and GA in relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis (SPMS) and clinically isolated syndrome (CIS) compared with best supportive care (BSC) and each other and a de novo economic model for CIS found DMTs were clinically effective but high risk of bias are high.
The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.
Dengue virus requires the CC‐chemokine receptor CCR5 for replication and infection development
Using an immunocompetent mouse model of DENV‐2 infection, it is found that CCR5−/− mice were resistant to lethal infection, presenting at least 100‐fold reduction of viral load in target organs and significant reduction in disease severity.
How do Australians living with MS experience oral health and accessing dental care? A focus group study
The findings suggest that there needs to be greater interprofessional communication and referral to manage atypical dental pain symptoms and policy and strategies to improve the oral health of people with MS should focus on enhancing access through transport, reducing the cost of dental services to the individual and providing domiciliary oral health care.
Managing the oral side‐effects of medications used to treat multiple sclerosis
This review aimed to identify the oral side-effects of the current drugs recommended in Australia to treat MS and make dental practitioners aware of the range of symptoms likely to be reported by this population of patients.


Immunology of Multiple Sclerosis.
MS-related factors such as localization of lesions, vulnerability of oligodendrocytes, neurons/axons, and secondary metabolic changes all play a role in the heterogeneous expression of the disease, including different pathologic lesion patterns, neuroimaging findings, disease courses, and severity and response to treatment.
Approaches to neuroprotective strategies in multiple sclerosis
MS has a long-term course of accumulating deficit in which neuroinflammation evolves into neurodegeneration, which require different treatment strategies – immune modulation and neuroprotection.
Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis
Previously considered to be caused by an autoimmune process mainly affecting myelin and oligodendrocytes in the white matter, recent data provide evidence that a generalized, diffuse neurodegenerative process plays an important role in the pathogenesis of MS.
Axonal transection in the lesions of multiple sclerosis.
Transected axons are common in the lesions of multiple sclerosis, and axonal transection may be the pathologic correlate of the irreversible neurologic impairment in this disease.
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem
A dipstick algorithm based on utilizing urinary dipstick testing allows for more rapid and safer management of UTIs in MS patients with acute relapses and assists them to reach diagnostic decisions and select the appropriate therapy earlier in the course of MS relapse.
Spread of T lymphocyte immune responses to myelin epitopes with duration of multiple sclerosis.
The data support the notion that the T cell response in MS broadens with time and is thus implicated in the ongoing pathogenic process, but there was no clear correlation between disease severity and number of epitopes recognized.
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
The majority of knowledge about the role of Th17 in MS pathogenesis is resulted in investigation into EAE animal models, and it is expected that Th17 cell to be as a potent pathogenic factor in disease immunopathophysiology.
The Role of Alpha-4 Integrin in the Aetiology of Multiple Sclerosis
The demonstration that selective modulation (blocking) of the adhesion molecule VLA-4 by natalizumab in MS, resembling that observed in experimental disease, represents a major advance in rational therapy.